VentriPoint Diagnostics Ltd.  

(Public, CVE:VPT)   Watch this stock  
Find more results for VPT
Feb 27 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.04 - 0.17
Open     -
Vol / Avg. 0.00/53,717.00
Mkt cap 8.36M
P/E     -
Div/yield     -
EPS 0.00
Shares 185.87M
Beta 0.79
Inst. own     -


100 W Harrison St Ste 410
SEATTLE, WA 98119-4116
United States - Map
+1-206-2830221 (Phone)
+1-425-7474163 (Fax)

Website links


VentriPoint Diagnostics Ltd. is a medical device company engaged in the development and commercialization of its diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates right heart volumetric measurements and a three-dimensional model VMS trade name is Angelo. The Company�s solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating knowledge based reconstruction (KBR) algorithms and disease-specific databases. The Company�s KBR method allows for the creation of a three-dimensional model of the right and/or left ventricle using images generated from existing two dimensional (2D) imaging equipment.

Officers and directors

Treuman P. Katz Independent Chairman of the Board
George Adams President, Chief Executive Officer, Director
Ellen Briant Chief Financial Officer, Corporate Secretary
Alan Rabinowitz Director
Danny Dalla-Longa Independent Director
Bradley Raines Harlow Independent Director